Literature DB >> 6781004

Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.

N A Garrick, D L Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6781004     DOI： 10.1007/BF00433804

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  25 in total

1.  The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

Authors:  W Birkmayer; P Riederer; M B Youdim; W Linauer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid.

Authors:  L J Major; D L Murphy; S Lipper; E Gordon
Journal:  J Neurochem       Date:  1979-01       Impact factor: 5.372

3.  Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase.

Authors:  C H Donnelly; D L Murphy
Journal:  Biochem Pharmacol       Date:  1977-05-01       Impact factor: 5.858

Review 4.  Substrate-selective monoamine oxidases--inhibitor, tissue, species and functional differences.

Authors:  D L Murphy
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

5.  Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.

Authors:  D S Robinson; W Lovenberg; H Keiser; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

6.  Dopamine is a monoamine oxidase B substrate in man.

Authors:  V Glover; M Sandler; F Owen; G J Riley
Journal:  Nature       Date:  1977-01-06       Impact factor: 49.962

7.  Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.

Authors:  J A Roth; K Feor
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

8.  Some observations on human brain monoamine oxidase [proceedings].

Authors:  A J Cross; V Glover; R Lofthouse; F Owen; T J Crow
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

9.  Brain region differences and some characteristics of monoamine oxidase type A and B activities in the vervet monkey.

Authors:  D L Murphy; D E Redmond; N Garrick; J Baulu
Journal:  Neurochem Res       Date:  1979-02       Impact factor: 3.996

10.  The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.

Authors:  C Braestrup; H Andersen; A Randrup
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432
View more
  33 in total

1.  Expression of monoamine oxidase B activity in astrocytes of senile plaques.

Authors:  S Nakamura; T Kawamata; I Akiguchi; M Kameyama; N Nakamura; H Kimura
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.

Authors:  R Heintz; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  An analgesic effect of enkephalinase inhibition is modulated by monoamine oxidase-B and REM sleep deprivations.

Authors:  O E Ukponmwan; J Rupreht; M Dzoljic
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

4.  A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.

Authors:  Sevil Yasar; József Gaál; Leigh V Panlilio; Zuzana Justinova; Szecsö V Molnár; Godfrey H Redhi; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

5.  The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions.

Authors:  E Scarr; D M Wingerchuk; A V Juorio; I A Paterson
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

6.  5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman.

Authors:  A Adell; R D Myers
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

7.  Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.

Authors:  M K Lakshmana; B S Rao; N K Dhingra; R Ravikumar; S Sudha; B L Meti; T R Raju
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

Review 8.  The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog.

Authors:  N W Milgram; G O Ivy; E Head; M P Murphy; P H Wu; W W Ruehl; P H Yu; D A Durden; B A Davis; I A Paterson
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

9.  Histochemistry of MAO-A and MAO-B in the locus coeruleus of the Mongolian gerbil.

Authors:  C Konradi; K Jellinger; P Riederer; T Nagatsu
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

10.  Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice.

Authors:  Marco Bortolato; Sean C Godar; Shieva Davarian; Kevin Chen; Jean C Shih
Journal:  Neuropsychopharmacology       Date:  2009-08-26       Impact factor: 7.853
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.